companydata.dkcompanydata.dk

Pharmaforce ApS: Financial statements 2024

CVR: 26394198

Source: annual report 2024, Danish Business Authority

01/01/202431/12/2024

Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 5,437,134 and a net result of DKK 1,494,355 compared with DKK 262,216 the year before. That is an increase of 47.6% compared with the year before. Equity in the 2024 report amounted to DKK 3,914,650. The solvency ratio was 63.5%. The company had 4 employees in the financial year.

Gross Profit
DKK 5,437,134
Profit/Loss
DKK 1,494,355
Equity
DKK 3,914,650
Total Assets
DKK 6,169,249
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-5.4 mio.1.5 mio.3.9 mio.4
2023-3.7 mio.262 t.2.9 mio.5
2022-3.6 mio.283 t.2.9 mio.5
2021-4.2 mio.367 t.2.9 mio.5
2020-4.3 mio.1.1 mio.2.5 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Pharmaforce ApS: The 2023 annual report is outMay 9, 2024

Pharmaforce ApS has published its annual report for 2023. Gross profit came to DKK 3,682,481, and the net result was DKK 262,216.

About Pharmaforce ApS

Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity in the 2025 report amounted to DKK 4,328,882.

Source: annual report 2025, Danish Business Authority